HighCost of Medication Regimens for Lung Cancer
Thearticle in consideration focuses on treatment costs of lung cancer.It also dwells on patient responsibility, stages of the disease andtreatment modality. As estimated by the World Health Organization(WHO), cancer is among the leading killer disease worldwide. As amatter of fact, it caused roughly 8.2 million deaths in the year2012. Death rates within wealthier countries are declining owing tothe early detections and treatments available. Middle and low incomecountries are faced with numerous challenges in combating cancerrelated ailments. The rates of lung cancer among middle and lowincome countries are continuously rising. Apart from the high costsof treatment, such countries lack adequate equipment to handle thedisease. In that regard, patients are diagnosed at later stages ofthe disease which are incurable or much expensive [ CITATION Hoe14 l 1033 ].
Aftergoing through the article, it is evident the cost of medicationrelated to lung cancer are quite high. The cost of medications forlung cancer are quite high in almost all the countries especiallydeveloping ones. The article suggests that the cost of medicationdepend on the extent of disease. For instance if it is at thebeginning it tends to be cheaper than at latter stages. Asexemplified in the article, the entire costs i.e. from diagnosis upto around two years stand at roughly $46,000. Hospitalizationaccounts for around 49 percent of the costs. Outpatient visits isattributed to around 35.2 percent of the costs. The initial monthlytreatment costs are around $11,500 per victim.
Trueto the articles findings, the costs medication continue to rise withtime. In other words, as years go by, the costs of medication alsoincrease. Newer inventions of treatment tend to come about withincreased amounts of cash. For instance, Chemotherapy is the mostcostly treatment option as earlier outlined. Continuous utilizationof such treatment ought to burden the affected patients economically.This article presents appropriate findings within the lung cancermedication aspect. Generally, the medications for cancer are quitehigh. The article does not only present the findings on lung cancer,instead it explores the other cancers affecting people across theglobe.
Asportrayed within the article, patients have a responsibility fortheir own health. The general public is also encouraged to beresponsible for their own health. Engaging too much in smoking amongother activities causing lung cancer is dangerous. As per thefindings, individuals have control over their own health and canchoose not to use disease causing substances. Avoidance of dangeroussubstances causing lung cancer is one major lesson obtained from thearticle. Before acquiring the sickness through voluntary actions, itis better to abstain so as to manage health.
Theinformation entailed within the article correlates effectively withthe lecture materials. High cost of medication regimes for lungcancer is core issue within the country. It also poses grater threatsin a global perspective. The issues vitality is also instigated bythe fact that research centers for cancer are filled withbureaucracy. Setting the prices is left at the mercy of researcherswho obtain the drugs. In that manner, prices are bound to be high andunaffordable to some patients. In that regard, there is need toaddress research bureaucracy as well as involve Medicare in pricenegotiations. As per the classwork, this article outlines an issueand its extent within the society. In addition to that, it providesthe solutions that can be implemented to eradicate the problem.
Cipriano, L. E. (2011). ). Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. . Value in Health, 41.52.
Hoen, E. (2014). Access to Cancer Treatment.
Kantarijian, H. S. (2014). High cancer drug prices in the United States:reasons and proposed solutions. Journal Of Oncology Practice, 10(4), e208-e211.
Robertson, R. H. (2004). Lung Cancer: A Cost and Outcome Study Based on Physician Practice Patterns. Lung Cancer: A Cost and Outcome Study Based on Physician Practice Patterns, 112-124.